Esophageal Squamous Cell Carcinoma

CLINICAL_TRIALS trial_result · 2021-11-08

Clinical Trial Update: The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer [Phase 3]

Phase 3 trial update evaluating Andrographis Paniculata for palliative management in advanced esophageal squamous cell carcinoma; study comp…

CLINICAL_TRIALS trial_result · 2021-11-02

Clinical Trial Update: Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy [Phase 2]

Phase 2 clinical trial evaluating salvage immunotherapy and chemotherapy in esophageal squamous cell carcinoma patients who did not respond …

CLINICAL_TRIALS trial_result · 2021-09-20

Clinical Trial Update: Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell [Phase 3]

Phase 3 trial evaluating SHR-1210 (PD-1 antibody) plus apatinib versus SHR-1210 alone as second-line treatment for advanced esophageal squam…

CLINICAL_TRIALS trial_result · 2021-09-16

Clinical Trial Update: Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest. [Phase 2]

Phase 2 clinical trial exploring immunodynamic monitoring during neoadjuvant chemotherapy immunotherapy in solid chest tumors, including non…

CLINICAL_TRIALS trial_result · 2021-09-08

Clinical Trial Update: The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]

Phase 2 clinical trial update for Ave-CRT in newly diagnosed metastatic esophageal squamous cell carcinoma.

CLINICAL_TRIALS trial_result · 2021-09-02

Clinical Trial Update: Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma [Phase 2]

A Phase 2 study evaluating anlotinib in combination with irinotecan for esophageal squamous cell carcinoma is underway, with status not spec…

CLINICAL_TRIALS trial_result · 2021-08-25

Clinical Trial Update: A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC [Phase 2]

Phase 2 trial evaluating sintilimab as consolidation therapy after radical chemoradiotherapy in locally advanced unresectable esophageal squ…

CLINICAL_TRIALS trial_result · 2021-08-24

Clinical Trial Update: Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. [Phase 2]

Phase 2 trial evaluating paclitaxel and cisplatin (DDP) combined with anlotinib as first-line therapy for advanced esophageal squamous cell …

CLINICAL_TRIALS trial_result · 2021-08-23

Clinical Trial Update: A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma [Phase 2]

A Phase 2 clinical trial assessing camrelizumab as adjuvant therapy for resectable esophageal squamous cell carcinoma.

CLINICAL_TRIALS trial_result · 2021-08-23

Clinical Trial Update: Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

Phase 2 clinical trial evaluating safety and effectiveness of toripalimab with neoadjuvant radiotherapy and chemotherapy for locally advance…

CLINICAL_TRIALS trial_result · 2021-07-30

Clinical Trial Update: Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade [Phase 2]

A phase 2 trial evaluating chidamide plus camrelizumab as second-line therapy for advanced esophageal squamous cell carcinoma after prior PD…

CLINICAL_TRIALS trial_result · 2021-07-13

Clinical Trial Update: Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification [Phase 2]

Phase 2 trial update exploring afatinib plus toripalimab in previously treated esophageal squamous cell carcinoma with EGFR overexpression o…

CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma [Phase 2]

Phase 2 trial investigating concurrent chemoradiotherapy after endoscopic resection for stage I esophageal carcinoma (esophageal squamous ce…

CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

Phase 2 trial evaluating SHR-1210 (anti-PD-1) plus nimotuzumab for advanced esophageal squamous cell carcinoma.

CLINICAL_TRIALS trial_result · 2021-05-06

Clinical Trial Update: Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus [Phase 2]

Phase 2 trial evaluating PDR001 in patients with unresectable or metastatic esophageal squamous cell carcinoma who failed standard treatment…

CLINICAL_TRIALS trial_result · 2021-04-29

Clinical Trial Update: An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody [Phase 2]

Phase 2 exploratory trial investigating SHR6390 and SHR1020 for esophageal squamous cell carcinoma after progression on PD-1 antibody therap…

CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 ) [Phase 2]

Phase 2 trial update for pembrolizumab in esophageal squamous cell carcinoma after radical surgery with positive lymph nodes (KEYSTONE-004).

CLINICAL_TRIALS trial_result · 2021-04-21

Clinical Trial Update: Chemoradiation and Panitumumab for Esophageal Cancer [Phase 2]

Phase 2 trial evaluating chemoradiation combined with panitumumab for esophageal cancer has completed.

CLINICAL_TRIALS trial_result · 2021-04-06

Clinical Trial Update: Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus [Phase 2]

Phase 2 trial update examining raltitrexed concurrent with radiotherapy in elder Chinese patients with esophageal squamous cell carcinoma.

CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma [Phase 2]

Phase 2 trial update investigating PET imaging-guided chemoradiotherapy for esophageal squamous cell carcinoma.

CLINICAL_TRIALS trial_result · 2021-03-15

Clinical Trial Update: SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer [Phase 2]

Phase 2 trial investigating SHR-1210 in combination with Anlotinib for advanced or metastatic esophageal squamous cell cancer.

CLINICAL_TRIALS trial_result · 2021-02-23

Clinical Trial Update: A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC) [Phase 2]

A Phase 2 clinical trial evaluating camrelizumab plus chemotherapy as neoadjuvant therapy for advanced esophageal squamous cell carcinoma is…

CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy [Phase 3]

Phase 3 clinical trial investigating megestrol acetate to improve quality of life in patients with esophageal squamous cell carcinoma underg…

CLINICAL_TRIALS trial_result · 2021-02-02

Clinical Trial Update: Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]

Phase 2 trial evaluating neoadjuvant PD-1 blockade plus chemotherapy for esophageal squamous cell carcinoma has completed.

CLINICAL_TRIALS trial_result · 2021-01-19

Clinical Trial Update: Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment [Phase 2]

Phase 2 trial of IBI308 in advanced/metastatic esophageal squamous cell carcinoma after failure of first-line treatment has completed.

Top drugs studied for this disease